| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1939) |
| Entry Type: | Oligosaccharide |
| Molecule Category: | Salt |
| UNII: | ZZ45AB24CA |
| Parent Compound: | HEPARIN |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ACTIVATOR | Antithrombin-III activator |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hip Fractures | 3 | D006620 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Kidney Failure, Chronic | 3 | D007676 | ClinicalTrials |
| Thrombosis | 3 | D013927 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
| Venous Thromboembolism | 3 | D054556 | ClinicalTrials |
| Acute Kidney Injury | 3 | D058186 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 1 | D045169 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1201657 |
| FDA SRS | ZZ45AB24CA |